Skip to Content
Merck
CN
  • Genetic contribution to lipid levels in early life based on 158 loci validated in adults: the FAMILY study.

Genetic contribution to lipid levels in early life based on 158 loci validated in adults: the FAMILY study.

Scientific reports (2017-03-03)
Shanice Christie, Sébastien Robiou-du-Pont, Sonia S Anand, Katherine M Morrison, Sarah D McDonald, Guillaume Paré, Stephanie A Atkinson, Koon K Teo, David Meyre
ABSTRACT

The contribution of polymorphisms associated with adult lipids in early life is unknown. We studied 158 adult lipid polymorphisms in 1440 participants (544 children, 544 mothers and 324 fathers) of the Family Atherosclerosis Monitoring In early life (FAMILY) birth cohort. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) measurements were collected at birth, 3 and 5 years of age. Polymorphisms were genotyped using the Illumina Cardio-Metabochip array. Genotype scores (GS) were calculated for TC, HDL-C, LDL-C and TG. Linear and mixed-effects regressions adjusted for sex, age and population stratification were performed. The GS was associated with LDL-C level at 3 and 5 years (β = 0.017 ± 0.003, P = 2.9 × 10

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
S-Nitroso-N-acetyl-DL-penicillamine, ≥97%, powder